1-5 of 5
Marta Sbaraglia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment

Roberta Sanfilippo, Marta Sbaraglia, Chiara Fabbroni, Sabrina Croce, Isabelle Ray-Coquard, Fatma Guermazi, Biagio Paolini, Félix Blanc-Durand, Axel Lecesne, Valentina Chiappa, Angelo Paolo Dei Tos, Paolo Giovanni Casali
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (22): 4679–4684.
https://doi.org/10.1158/1078-0432.CCR-23-0692
Published: 14 November 2023
View article titled, Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment
Open the PDF for Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment in another window
Journal Articles

Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study

Bruno Vincenzi, Andrea Napolitano, Marta Fiocco, Olivier Mir, Piotr Rutkowski, Jean-Yves Blay, Peter Reichardt, Heikki Joensuu, Elena Fumagalli, Spyridon Gennatas, Nadia Hindi, Margherita Nannini, Mariella Spalato Ceruso, Antoine Italiano, Giovanni Grignani, Antonella Brunello, Silvia Gasperoni, Tommaso De Pas, Giuseppe Badalamenti, Maria A. Pantaleo, Winan J. van Houdt, Nikki S. IJzerman, Neeltje Steeghs, Hans Gelderblom, Ingrid M.E. Desar, Johanna Falkenhorst, Marianna Silletta, Marta Sbaraglia, Giuseppe Tonini, Javier Martin-Broto, Peter Hohenberger, Axel Le Cesne, Robin L. Jones, Angelo P. Dei Tos, Alessandro Gronchi, Sebastian Bauer, Paolo G. Casali
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1672–1679.
https://doi.org/10.1158/1078-0432.CCR-21-1665
Published: 14 April 2022
View article titled, Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study
Open the PDF for Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study in another window
Includes: Supplementary data
Journal Articles

Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors

Roberta Sanfilippo, Chiara Fabbroni, Giovanni Fucà, Elena Fumagalli, Carlo Morosi, Marta Sbaraglia, Alessandro Gronchi, Paola Collini, Angelo P. Dei Tos, Paolo G. Casali
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (20): 5534–5538.
https://doi.org/10.1158/1078-0432.CCR-20-1191
Published: 15 October 2020
View article titled, Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors
Open the PDF for Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors in another window
Includes: Supplementary data
Journal Articles

Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

Roberta Sanfilippo, Robin L. Jones, Jean-Yves Blay, Axel Le Cesne, Salvatore Provenzano, Georgios Antoniou, Olivier Mir, Giovanni Fucà, Elena Fumagalli, Rossella Bertulli, Silvia Stacchiotti, Mehdi Brahmi, Federica Grosso, Armelle Dufresne, Nadia Hindi, Marta Sbaraglia, Alessandro Gronchi, Paola Collini, Angelo P. Dei Tos, Paolo G. Casali
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (17): 5295–5300.
https://doi.org/10.1158/1078-0432.CCR-19-0288
Published: 03 September 2019
View article titled, Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)
Open the PDF for Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas) in another window
Includes: Supplementary data
Journal Articles

Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome

Daniela Gasparotto, Sabrina Rossi, Maurizio Polano, Elena Tamborini, Erica Lorenzetto, Marta Sbaraglia, Alessia Mondello, Marco Massani, Stefano Lamon, Raffaella Bracci, Alessandra Mandolesi, Elisabetta Frate, Franco Stanzial, Jerin Agaj, Guido Mazzoleni, Silvana Pilotti, Alessandro Gronchi, Angelo Paolo Dei Tos, Roberta Maestro
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1): 273–282.
https://doi.org/10.1158/1078-0432.CCR-16-0152
Published: 02 January 2017
View article titled, Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome
Open the PDF for Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome in another window
Includes: Supplementary data